Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:nonprofit_organization
|
| gptkbp:CEO |
Fernando Vieira
|
| gptkbp:collaboratesWith |
academic institutions
pharmaceutical companies ALS patient community |
| gptkbp:focus |
amyotrophic lateral sclerosis research
|
| gptkbp:founded |
1999
|
| gptkbp:founder |
gptkb:James_Heywood
|
| gptkbp:fullName |
gptkb:ALS_Therapy_Development_Institute
|
| gptkbp:fundedBy |
grants
donations |
| https://www.w3.org/2000/01/rdf-schema#label |
ALS TDI
|
| gptkbp:location |
gptkb:Watertown,_Massachusetts,_USA
|
| gptkbp:mission |
to discover and develop effective treatments for ALS
|
| gptkbp:notableProject |
gptkb:ALS_Research_Collaborative
gptkb:Precision_Medicine_Program ALS House Call Program |
| gptkbp:researchModel |
preclinical drug screening
|
| gptkbp:taxStatus |
gptkb:nonprofit_organization
|
| gptkbp:type |
biomedical research organization
|
| gptkbp:website |
https://www.als.net/
|
| gptkbp:bfsParent |
gptkb:ALS_Therapy_Development_Institute
|
| gptkbp:bfsLayer |
7
|